CQENS Technologies Inc. financial data

Industry
Pharmaceutical Preparations
Location
5550 Nicollet Avenue, Minneapolis, MN
State of incorporation
Delaware
Fiscal year end
December 31
Former names
VapAria Corp (to 12/18/2019), OICco ACQUISITION IV, INC. (to 8/12/2014)
Latest financial report
10-Q - Q2 2024 - Aug 16, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 89.8 % +14.8%
Debt-to-equity 94.4 % +85.8%
Return On Equity -227 % +42.6%
Return On Assets -117 % +55.5%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 26.6M shares +1.82%
Common Stock, Shares, Outstanding 26.4M shares +1.14%
Entity Public Float 0 USD
Common Stock, Value, Issued 2.64K USD +1.15%
Weighted Average Number of Shares Outstanding, Basic 26.2M shares +0.64%
Weighted Average Number of Shares Outstanding, Diluted 26.2M shares +0.64%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 1.22M USD -10.2%
General and Administrative Expense 1.23M USD -50.3%
Operating Income (Loss) -892K USD +18.3%
Net Income (Loss) Attributable to Parent -3.91M USD +36.4%
Earnings Per Share, Basic 0.18 USD/shares -25%
Earnings Per Share, Diluted 0.18 USD/shares +25%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 3.38M USD +870%
Assets, Current 3.71M USD +779%
Property, Plant and Equipment, Net 148K USD -12%
Operating Lease, Right-of-Use Asset 54.2K USD -49.9%
Intangible Assets, Net (Excluding Goodwill) 1.21M USD +18%
Assets 5.65M USD +158%
Accounts Payable, Current 144K USD +6.16%
Accrued Liabilities, Current 411K USD +37.1%
Liabilities, Current 1.87M USD +33.9%
Operating Lease, Liability, Noncurrent 4.03K USD -92.8%
Liabilities 1.87M USD +29.2%
Accumulated Other Comprehensive Income (Loss), Net of Tax -19 USD
Retained Earnings (Accumulated Deficit) -25.7M USD -17.9%
Stockholders' Equity Attributable to Parent 3.79M USD +405%
Liabilities and Equity 5.65M USD +158%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -350K USD +49.5%
Net Cash Provided by (Used in) Financing Activities 415K USD -34.1%
Net Cash Provided by (Used in) Investing Activities -64.5K USD -12.2%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 26.4M shares +1.14%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -121K USD +87.9%
Deferred Tax Assets, Valuation Allowance 374K USD +22.2%
Operating Lease, Liability 54.2K USD -49.9%
Depreciation 5.04K USD 0%
Payments to Acquire Property, Plant, and Equipment 7.8K USD
Lessee, Operating Lease, Liability, to be Paid 55.6K USD -51.2%
Operating Lease, Liability, Current 54.2K USD -6.15%
Lessee, Operating Lease, Liability, to be Paid, Year Two 20.7K USD -64.1%
Lessee, Operating Lease, Liability, to be Paid, Year One 22.2K USD -64.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.31K USD -76.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three 19.2K USD
Deferred Tax Assets, Operating Loss Carryforwards 374K USD +22.2%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Operating Lease, Payments 66.7K USD
Additional Paid in Capital 29.5M USD +30.8%
Preferred Stock, Shares Outstanding 0 shares
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%